AUTLNasdaq

Autolus Therapeutics plc

Biological Products, (No Diagnostic Substances) · X0 · CIK 1730463

Developing, manufacturing, and delivering next-generation T cell therapies for cancer and autoimmune diseases

red 8-K · 90d

$415M

Market cap

$1.65

Last close

+2.5%

+10.7%

960K

Volume

Price · last 39 sessions+5.1%

May 4L $1.46 · H $1.87Jun 29

143

Total filings

Jun 29, 2026

Last filing

12/31

Fiscal year end

Similar companies

Comparable business profile · signals at a glance